These Analysts Just Made A Decent Downgrade To Their Arcus Biosciences, Inc....

Published on 20 Feb 2025 on Simply Wall St. · via Yahoo Finance

One thing we could say about the analysts on Arcus Biosciences, Inc. (NYSE:RCUS) - they aren't...

Read the rest of the article

Start tracking your investments with Statfolio

Gilead Sciences, Inc. (NASDAQ:GILD) recently expanded its stake in Arcus Biosciences, Inc....

Investing.com 20 Feb 2025

One thing we could say about the analysts on Arcus Biosciences, Inc. (NYSE:RCUS) - they aren't...

Simply Wall St. · via Yahoo Finance 20 Feb 2025

Arcus Biosciences, Inc. (NASDAQ:NYSE:RCUS), a biotechnology company with a market capitalization ...

Investing.com 18 Feb 2025

Arcus Biosciences Inc (RCUS) reports robust financial health and strategic advancements in...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Arcus Biosciences Inc (NYSE:RCUS) is set to release its Q3 2024 earnings on Nov 6, 2024. The...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Cash and Investments: $1 billion as of June 30, 2024.GAAP Revenue: $39 million for the second qua...

GuruFocus.com · via Yahoo Finance 8 Oct 2024

Key Insights Arcus Biosciences' Annual General Meeting to take place on 6th of JuneSalary of US$6...

Simply Wall St. via Yahoo Finance 31 May 2024

Arcus Biosciences, Inc. (NYSE:RCUS) investors will be delighted, with the company turning in some...

Simply Wall St. via Yahoo Finance 12 May 2024

Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript May 8, 2024 Arcus Bioscience...

Insider Monkey via Yahoo Finance 9 May 2024

The market expects Arcus Biosciences, Inc. (RCUS) to deliver a year-over-year increase in earning...

Zacks via Yahoo Finance 1 May 2024